Showing results 21 to 40 of 168
< previous
next >
| Issue Date | Title | Author(s) |
| 2011 | Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells | Avcı, Çığır Biray; Gündüz, Cumhur; Baran, Yusuf ; Şahin, Fahri; Yılmaz, Sunde; Doğan, Zeynep Özlem; Saydam, Güray |
| Nov-2016 | Cell proliferation and cytotoxicity assays | Adan, Aysun ; Kiraz, Yağmur ; Baran, Yusuf |
| 2010 | Ceramides regulate resveratrol-induced apoptosis in human acute promyelocytic and chronic myeloid leukemia cells | Baran, Yusuf ; Kartal, Melis; Çakır, Zeynep; Saydam, Güray; Şahin, Fahri |
| 2010 | Changes in expression profiles of apoptosis, invasion, metastasis, angiogenesis, transcription factors, cell cycle control and tumour supressor genes in nilotinib treated chronic myeloid leukemia cells | Baran, Yusuf ; Camgöz, Aylin; Can, Geylani |
| 2013 | Changes in gene expression profiles in response to apigenin in imatinib sensitive and resistant chronic myeloid leukemia cells | Baran, Yusuf ; Gökbulut, Aysun ; Cincin, Zeynep; Çakmakoğlu, Bedia; Kozanoğlu, İlknur |
| 2013 | Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era | Cömert, Melda; Baran, Yusuf ; Saydam, Güray |
| May-2013 | Changes in protein profiles of multiple myeloma cells in response to bortezomib | Turan, Taylan; Şanlı Mohamed, Gülşah ; Baran, Yusuf |
| Jun-2010 | Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells | Baran, Yusuf ; Öztekin, Coşkun; Başsoy, Esen Yonca |
| Sep-2014 | Comparative development of knowledge-based bioeconomy in the European Union and Turkey | Çelikkanat Ozan, Didem; Baran, Yusuf |
| 2014 | Comparison of ishage-based CD34 (+) cell enumeration protocols on BD facs canto ıı and attune flow cytometers | Kozanoğlu, İlknur; Ünver, Gülşah; Sarıtürk, Çağla; Baran, Yusuf ; Yeral, Mahmut; Boğa, Can; Özdoğu, Hakan |
| 2012 | Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia | Baran, Yusuf ; Saydam, Güray |
| 2014 | Cytotoxic and apoptotic effects of fisetin, hesperetin and vitexinon acute promyelocytic leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2014 | Cytotoxic and cytostatic effects of ponatinib on imatinib-sensitive and-resistant chronic myeloid leukemia cells | Yandım, Melis Kartal; Baran, Yusuf |
| 2013 | Cytotoxic effects of apigenin on multiple myeloma cells | Baran, Yusuf ; Yılmaz, S. ; Cincin, Zeynep; Kozanoğlu, İlknur; Çakmakoğlu, Bedia; Özdoğu, Hakan |
| 2010 | Cytotoxic effects of resveratrol on imatinib sensitive and resistant K562 chronic myeloid leukemia cells | Can, Geylani; Baran, Yusuf |
| 2011 | Deciphering 5-fluorouracil mediated molecular mechanisms required for cell death | Can, Geylani |
| 2013 | Determination of cytotoxic and apoptotic effects of caffeic acid phenethyl ester and gossypol in combination with fludarabine at a molecular level in acute lymphoblastic leukemia cells | Baran, Yusuf ; İskender, G.; Pişkin, Özden; Özcan, Mehmet Ali |
| Jul-2021 | Determination of therapeutic effects of multifunctional antibody and peptide micelle-based nanocarriers on breast cancer cells | Abdulhadi, Nusaibah Abdulsalam Abdulhad |
| Jul-2019 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe |
| 2021 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe ; Bayram, Nazende Nur; Abdulhadi, N.; Gurdap, S.; Isoglu, A.; Isoglu, S. D.; Baran, Yusuf |
